Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a pDNA Vaccine Candidate Against COVID-19 in Healthy Adults Not authorised

2023-505135-12-00 Covid-19 Prophylaxis 1
A geroscience approach to post-acute COVID-19 syndrome (PACS) by Diet and Exercise plus rapamycin or metformin to treat Frailty and restore … Not authorised

2023-504641-32-00 Post-acute COVID syndrome(PACS) diagnosis. 4
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post COVID-1… Not authorised

2023-504087-42-00 Post COVID-19 5
Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections (IMPACT) Not authorised

2025-522215-42-00 Severe acute infection 6
An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study) Not authorised

2023-508444-22-00 Chronic hepatitis B infection 1
A clinical study of people with HIV‐1 who switch their treatment to a combination of doravirine and islatravir Not authorised

2022-502079-49-00 HIV-1 infection 5
A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi… Not authorised

2022-502099-22-00 HIV-1 Infection 5
A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised

2022-502126-40-00 HIV-1 infection 5
A clinical study of people with HIV-1 who take antiretroviral therapy and switch their treatment to a combination of doravirine and islatrav… Not authorised

2022-502127-22-00 HIV-1 Infection 5
Treatments of COVID-19 in primary care in the Netherlands Not authorised

2022-500678-33-00 Patients with COVID-19 in the community, referred by th 6
RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Not authorised

2024-511580-28-00 PASC: post-acute sequelae of SARS-CoV-2 infection 5
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT. Not authorised

2024-517002-28-00 graft-versus-host disease 3
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine when Given to Healthy Children 3 Month… Not authorised

2024-516635-27-00 Varicella 5
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study Not authorised

2025-522611-42-00 Long Covid 5
Double-blind randomized controlled study versus placebo to evaluate the efficacy of mono-administration of betamethasone in children with sy… Pending

2024-518095-31-00 Adenovirus infection 5
Assessing the efficacy of Elixirium thymi compositum in the treatment of acute bronchitis in pediatric patients (EXOTIC): A double-blind, ra… Pending

2025-520845-61-00 Acute bronchitis 6
Evaluation of Influenza Vaccine Immune Response in Obesity (VaccObFlu) Pending

2025-522698-13-00 Influenza, Obesity, Type 2 diabetes 6
Tick-Borne Encephalitis (TBE) Remdesivir Efficacy Assessment Trial (TREAT) Pending

2025-523476-23-00 Tick-Borne Encephalitis (TBE) 4
COPD-2VAX: Enhancing Protection Against Respiratory Infections Through AS01-Mediated Innate Immune Activation in High-Risk Patients Pending

2024-519163-18-00 Chronic Obstructive Pulmonary Disease (COPD) 6
Evaluation of the safety and efficacy of Bevacizumab in patients with persistent respiratory disorders after COVID-19 infection Pending

2024-520308-24-00 Adult patients with persistent dyspnea more than 3 mont 4
Effectiveness of a preventive strategy for cytomegalovirus infection guided differently from a universal prophylactic strategy in kidney tra… Pending

2024-515925-27-00 CMV 5
Herpes zoster after recombinant herpes zoster vaccination - Immediate post-RHZ-vaccination evolution of CMI, HMI and lymphocyte count and ty… Pending

2025-521547-20-00 Herpes Zoster virus prevention 6
Clinical trial on the virucidal activity of different oral antiseptics against respiratory viruses. Pending

2024-515939-30-01 Respiratory diseases 6
Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone … Pending

2025-522756-97-00 COVID-19 and Severely Impaired B-cell Function 4